MedTrace Logo

Sankofa Paradigm: A Therapeutic Theatre Program for Girls

NCT04518397 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2024-05-21

No results posted yet for this study

Summary

The purpose of this study is to test the impact of a 6-week theatre intervention rooted in African culture (Sankofa) on the wellness of girls (predominately African American) ages 8-18 receiving services at five Boys \& Girls Club Indianapolis sites. Theatre interventions are led by Asante theatre personnel and evaluated by the PI and occupational therapy graduate students. The theatre intervention being evaluated has been conducted for decades by an established theatre company with widespread community participation and anecdotal positive responses, but has not been scientifically evaluated to understand how it impacts wellbeing. This will be the first large-scale study of the mechanisms of change and of the impact of the theatre intervention in the community and will help to guide future therapeutic interventions using theatre with underserved populations.

Research questions include: Is Sankofa a feasible and acceptable intervention for the target population? Does participation in Sankofa result in improved scores on wellness outcome measures, including the National Youth Outcomes Initiative (NYOI) survey?

The study is funded by Asante Children's Theatre via the Central Indiana Community Foundation Women's Fund.

Conditions

  • Adolescent Behavior
  • Child Behavior
  • Mental Health Wellness 1
  • Mental Health Wellness 2

Interventions

BEHAVIORAL

Theatre

6-week participatory arts culturally-informed theatre program

Sponsors & Collaborators

  • Boys & Girls Clubs of Indianapolis

    collaborator UNKNOWN

  • Community Health Network

    collaborator OTHER

  • Indiana University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2024-05-10
Completion
2024-05-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04518397 on ClinicalTrials.gov